Navigation Links
Experimental nonsteroidal treatment of asthma shows promise
Date:7/1/2010

A new nonsteroidal, anti-inflammatory therapy made from a human protein significantly decreases disease signs of asthma in mice, opening the possibility of a new asthma therapy for patients who do not respond to current steroid treatments. Results of this therapy in an animal model were presented at The Endocrine Society's 92nd Annual Meeting in San Diego.

The protein, insulin-like growth factor binding protein-3 (IGFBP-3), uniquely inhibits specific physiological consequences of asthma examined in asthmatic mice, said Youngman Oh, PhD, a study co-author and a professor of pathology at Virginia Commonwealth University, Richmond, Virginia.

IGFBP-3 reportedly targets a key cellular pathway called nuclear factor kappa B, or NF-κB that plays a role in inflammation. The IGFBP-3 protein interferes with its cellular signaling and suppresses NF-κB activity.

"This novel mechanism has never been identified before. Our findings could have major implications not only for asthma but also other inflammatory diseases that NF-κB plays a role in, such as atherosclerosis and rheumatoid arthritis," Oh said.

In asthma, when the airways become inflamed, they become hyperreactive, or overly sensitive, to "triggers," such as dust, smoke and pet dander. This leads to a chain of reactions that elicit an asthma "attack". According to the American Lung Association nearly 23 million people have asthma, of which 9 million are children.

"Anti-inflammatory corticosteroid medicines are an important part of asthma management for many people, but an estimated 20 percent of patients with asthma are resistant to existing steroid medications and there is a critical need for alternate therapies," Oh said.

Using a mouse model, Oh and his colleagues showed that IGFBP-3 production is suppressed in asthma. They measured NF-κB inflammatory activity, using molecular and cellular techniques, and found that treatment with IGFBP-3 bloc
'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Experimental stem cell treatment arrests acute lung injury in mice, study shows
2. Experimental Drug Offers Hope for Cystic Fibrosis Patients
3. Experimental Vaccine Shields Monkeys Against Ebola
4. Experimental targeted therapy shows early promise against medulloblastomas
5. Steroids May Be Overrated in Treatment of COPD
6. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
7. New study shows effectiveness of MEND program in prevention and treatment of pediatric obesity
8. New York City Surgeon Develops All-Natural Treatment for Wrinkles and Scars
9. Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts
10. Northeast Chiropractic, PC Revolutionizes Pain Management Without Medication, Now Offering New and Unique Blend of Treatments
11. Autism-Supplements.com and Generation Rescue Work Together to Raise Money for Biomedical Autism Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Pomona, NY (PRWEB) May 18, 2013 Dr. ... sleep apnea dentistry, employs his knowledge of the ... in sleep apnea patients. With May being Better Sleep Month, ... have some sort of chronic sleep disorder, and sleep apnea ... With sleep apnea, a person will essentially stop breathing at ...
(Date:5/18/2013)... The topics that will be covered in the 1-day Agile ... scrum artifacts, and scrum simulation (optional). One can earn eight ... trainings are suitable for business analysts, project managers, developers, testers, ... be a part of the Scrum team, people outside the ... Scrum, but are unsure of what it is. , ...
(Date:5/18/2013)... Kimono condoms assorted sampler packs ... recently announced. Condomania recently added new Kimono condoms ... condoms from all over the world. The new ... different condom styles from one of the most popular ... shape and secure, the new packs contain something for ...
(Date:5/18/2013)... Provo, UT (PRWEB) May 18, 2013 Medical ... pre-launch orders for its much anticipated mobility aid with its ... to create a hands-free crutch alternative that injured ... a broken ankle, for example, can remain active and walk ... team is using its reservation system to ensure those who ...
(Date:5/18/2013)... OH (PRWEB) May 18, 2013 The product ... Skechers lawsuits on behalf of consumers nationwide who have ... of Shape-Ups toning shoes. These cases are all part of ... These Skechers lawsuits will be heard in the ... Division. , Wright & Schulte, LLC specializes in defending ...
Breaking Medicine News(10 mins):Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Kimono Condoms Assorted Sampler Packs Now Available at Condomania 2Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4
... Researchers in New York City say they are the first ... cells. A team at Albert Einstein College of Medicine ... gene transcription in living yeast cells, they say. Transcription occurs ... messenger RNA (mRNA) that then make the protein coded by ...
... , WEDNESDAY, April 27 (HealthDay News) -- Doctors are far ... for an expensive MRI scan if they own or lease ... University School of Medicine researchers also found that after orthopedists ... have back surgery within six months of seeing the orthopedist ...
... News) -- Reading a book can satisfy the crucial human ... research involved 140 university students who were given 30 minutes ... novel Twilight or the wizard novel Harry ... the lives of either vampires or wizards. The participants ...
... Society for Radiation Oncology (ASTRO) has developed a guideline ... brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused ... in Practical Radiation Oncology , an official journal ... receive radiation therapy to treat symptoms related to cancer, ...
... Edmonton Researchers in the Faculty of Medicine & Dentistry ... that provides a new understanding of how our immune system ... affect the way doctors treat patients with autoimmune diseases and ... part of experimental therapies to treat autoimmune diseases such as ...
... on a roadside and rushed to the University of Rochester Medical ... breakdown, doctors were surprised to discover that a trendy tea derived ... The URMC team reported the case study, believed to be the ... American Journal of Emergency Medicine . They described it ...
Cached Medicine News:Health News:Researchers Describe Gene Activity in Living Cells 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 3Health News:ASTRO publishes evidence-based guideline for thoracic radiotherapy 2Health News:Discovery could change the way doctors treat patients with cancer and autoimmune diseases 2Health News:Medical sleuthing linked muscle, kidney problems to kava tea 2Health News:Medical sleuthing linked muscle, kidney problems to kava tea 3
(Date:5/17/2013)... , May 17, 2013  PENTAX Medical, a ... Medical, a global leader in ultrasound imaging, recently ... companies to enable further innovation in the development ... Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic portfolio ... families of EUS systems. This agreement will continue ...
(Date:5/17/2013)... Sinovac Biotech Ltd. (Nasdaq: SVA ), ... , today announced that it will release its unaudited financial ... market on Tuesday, May 28, 2013.  The Company will host ... a.m. EDT (May 28, 2013 at 8:00 p.m. China Standard ... update on recent corporate developments. To access the ...
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... , LISBON, Portugal, September 11 ... Confirms Superiority of the New Intranasal Treatment,for Breakthrough Cancer Pain ... today further demonstrate the efficacy of Instanyl in,management of breakthrough ... of the European Federation of Chapters of the International,Association for ...
... , THOUSAND OAKS, Calif., Sept. 10 ... new data will be presented on the burden of osteoporosis, ... American Society for Bone and Mineral Research (ASBMR) annual meeting ... being evaluated by regulatory bodies in the United States (U.S.), ...
Cached Medicine Technology:Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 2Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 3Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 2Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 3Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 5Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 6Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 7Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 8
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
The CapSure Z Novus is an endocardial, tined, high-efficiency lead. High efficiency combined with steroid elution allows safe, low output programming....
The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
Medicine Products: